Indaptus Therapeutics share price logo

Indaptus Therapeutics

NASDAQ: INDP

$0.94

+0.00

(+0.42%)

as on

Indaptus Therapeutics Stock Performance

as on August 20, 2026 at 2:15 pm IST

  • Day's Low

    Day's High

    $0.93
    $1.11
    downward going graph

    1.06%

    Downside

    18.09%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.92
    $8.57
    downward going graph

    2.13%

    Downside

    811.70%

    Upside

    downward going graph

Indaptus Therapeutics share price movements today

Previous Close
$0.94
Open
$0.94
Volume
1.7M
Market Cap
$142.6M
Day's Low - High
$0.93 - $1.11
52 Week Low - High
$0.92 - $8.57

Indaptus Therapeutics Historical Returns

1 Month Return
-57.71 %
3 Month Return
-32.7 %
1 Year Return
-84.97 %
3 Year Return
-98.4 %
5 Year Return
-99.52 %

Indaptus Therapeutics Stock Fundamentals & Key Indicators

Check Indaptus Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$142.6M

EPS (TTM)

-6.43

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-19.8M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-318.04%

Indaptus Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Indaptus Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$142.6M-99.52%NA0.00%NA
BUY$43.7B669.3%NA0.00%NA
BUY$128.2B154.86%29.8286.04%NA
BUY$82.7B24.1%19.2484.86%0.44999999999999996%

Stock Returns calculator for Indaptus Therapeutics Stock including INR - Dollar returns

The Indaptus Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Indaptus Therapeutics investment value today

Current value as on today

₹14,518

Returns

-₹85,482

(-85.48%)

Returns from Indaptus Therapeutics Stock

-₹86,798 (-86.8%)

Dollar Impact

₹1,315 (+1.32%)

Analyst Recommendation on Indaptus Therapeutics Stock

Based on 8 analysts

BUY

87.50%

Buy

12.50%

Hold

0.00%

Sell

Based on 8 analysts, 87.5% of analysts recommend a 'BUY' rating for Indaptus Therapeutics. Average target price of $10

Indaptus Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Indaptus Therapeutics.

What analysts predicted

90.6%UPSIDE

Target Price

$10

Current Price

$0.94

Analyzed by

8 Analysts

Target

$10.00

Indaptus Therapeutics target price $10, a slight upside of 90.6% compared to current price of $0.94. According to 8 analysts rating.

Indian Investors' Interest in Indaptus Therapeutics Stock

Search interest for Indaptus Therapeutics Stock has decreased by -19% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-19% versus previous 30 day period

Indaptus Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Total Revenue
-
-
-
0
-
-
-
-
-
Gross Profit
0
-
-
0
-
-
-
-
-
Operating Income
-3
-4
-3
-4
-4
-4
-2
-8
-2
EBITDA
-3
-4
-3
-4
-4
-5
-2
-8
-2
Interest Expense
-
-
-
-
-
-
-
-
-
Depreciation
0
-
-
-
-
-
-
-
-
Income Before Tax
-3
-4
-3
-4
-4
-5
-2
-8
-2
Income Tax Expense
0
-
-
0
-
-
-
-
-
Net Income
-3
-4
-3
-4
-4
-5
-2
-8
-2
Net Profit Margin
0.00%
0.00%
0.00%
-281023.61%
0.00%
0.00%
0.00%
0.00%
0.00%

Indaptus Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
Gross Profit
0
0
0
0
0
-
Operating Income
-3
-7
-14
-16
-15
-19
EBITDA
-3
-7
-14
-15
-15
-20
Interest Expense
0
0
0
-
-
-
Depreciation
0
0
0
0
0
-
Income Before Tax
-3
-7
-14
-15
-15
-20
Income Tax Expense
0
0
0
-16
-
-
Net Income
-3
-7
-14
-15
-15
-20
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Indaptus Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-4
-3
-4
-4
-5
-2
-8
-2
-1
Operating Cash Flow
-2
-2
-3
-5
-4
-3
-3
-7
-1
Investing Cash Flow
-
-
-
-
-
-
-
-
-4
Financing Cash Flow
0
2
1
3
6
2
5
-
11
Change in Cash
-2
0
-1
-1
2
0
2
-7
6

Indaptus Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-28
-43
-47
-3
-7
-14
-15
-15
-20
Operating Cash Flow
-22
-39
-29
-3
-11
-13
-13
-12
-14
Investing Cash Flow
-4
-9
-3
0
0
-16
17
-
-
Financing Cash Flow
63
35
2
1
48
0
-
4
17
Change in Cash
36
-14
-29
-2
37
-29
3
-7
2

Mutual Funds that own Indaptus Therapeutics Stock

Check out the Mutual Funds with significant holdings in Indaptus Therapeutics.

Funds
Holdings
Shares Held
Fidelity Concord Street Trust
0.008016%
9078

Global Institutional Holdings in Indaptus Therapeutics

Funds
Holdings
Vanguard
0.03%
Morgan Stanley
0.01%
TIH Funds
0%

Insights on Indaptus Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 624.7% return, outperforming this stock by 723.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Revolution Medicines, Inc. Common Stock has given 493.6% return, outperforming this stock by 580.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, INDP stock has moved down by -11.3%

About Indaptus Therapeutics

Indaptus Therapeutics, Inc., a clinical biotechnology company, engages in the development of various anti-cancer and anti-viral immunotherapy products. Its lead clinical candidate consists of Decoy20, which is used to produce single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, and chronic hepatitis B virus, and human immunodeficiency virus infection, as well as for the treatment of advanced solid tumors. The company was formerly known as Intec Parent, Inc. and changed its name to Indaptus Therapeutics, Inc. in August 2021. Indaptus Therapeutics, Inc. is headquartered in New York, New York.
OrganisationIndaptus Therapeutics
HeadquartersThree Columbus Circle, New York, NY, United States, 10019
IndustryBiotechnology
CEOMr. Junyi Dai
E-voting on sharesClick here to vote

Key Management of Indaptus Therapeutics

Name

Title

Mr. Junyi Dai

CEO & Chairman

Mr. Yu Ding

Chief Financial Officer

FAQs

What is Indaptus Therapeutics share price today?

Indaptus Therapeutics share price today is $0.94 as on at the close of the market. Indaptus Therapeutics share today touched a day high of $1.11 and a low of $0.93.

What is the 52 week high and 52 week low for Indaptus Therapeutics share?

Indaptus Therapeutics share touched a 52 week high of $8.57 on and a 52 week low of $0.92 on . Indaptus Therapeutics stock price today i.e. is closed at $0.94,which is 89.03% down from its 52 week high and 2.17% up from its 52 week low.

What is Indaptus Therapeutics's market capitalisation today?

Indaptus Therapeutics market capitalisation is $0.00T as on .

How to invest in Indaptus Therapeutics Stock (INDP) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Indaptus Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Indaptus Therapeutics Shares that will get you 1.5957 shares as per Indaptus Therapeutics share price of $0.94 per share as on August 20, 2026 at 8:45 am IST.

What is the minimum amount required to buy Indaptus Therapeutics Stock (INDP) from India?

Indian investors can start investing in Indaptus Therapeutics (INDP) shares with as little as ₹95.743 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.43 in Indaptus Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Indaptus Therapeutics share’s latest price of $0.94 as on August 20, 2026 at 8:45 am IST, you will get 10.6383 shares of Indaptus Therapeutics. Learn more about fractional shares .

What are the returns that Indaptus Therapeutics has given to Indian investors in the last 5 years?

Indaptus Therapeutics stock has given -99.52% share price returns and 28.54% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?